======= TAOK1 ======= == Gene Information == * **Official Symbol**: TAOK1 * **Official Name**: TAO kinase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57551|57551]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7L7X3|Q7L7X3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TAOK1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAOK1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610266|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade. {ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16407310, ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:17900936}. |Pkinase Tyr| |Pkinase| |mitotic G2 DNA damage checkpoint| |MAP kinase kinase kinase activity| |tau-protein kinase activity| |negative regulation of microtubule depolymerization| |mitotic G2/M transition checkpoint| |regulation of microtubule depolymerization| |protein serine/threonine kinase activator activity| |G2 DNA damage checkpoint| |neuron cellular homeostasis| |negative regulation of microtubule polymerization or depolymerization| |beta-tubulin binding| |alpha-tubulin binding| |activation of JUN kinase activity| |positive regulation of protein acetylation| |tau protein binding| |activation of MAPKK activity| |execution phase of apoptosis| |transferase activity| |negative regulation of protein depolymerization| |negative regulation of protein complex disassembly| |regulation of protein acetylation| |positive regulation of JUN kinase activity| |kinase activity| |regulation of microtubule polymerization or depolymerization| |JNK cascade| |regulation of protein depolymerization| |regulation of JUN kinase activity| |negative regulation of G2/M transition of mitotic cell cycle| |mitotic DNA damage checkpoint| |negative regulation of cell cycle G2/M phase transition| |mitotic DNA integrity checkpoint| |stress-activated MAPK cascade| |regulation of protein complex disassembly| |negative regulation of supramolecular fiber organization| |DNA damage checkpoint| |positive regulation of JNK cascade| |negative regulation of cytoskeleton organization| |stress-activated protein kinase signaling cascade| |DNA integrity checkpoint| |microtubule cytoskeleton| |mitotic cell cycle checkpoint| |activation of MAPK activity| |positive regulation of stress-activated MAPK cascade| |positive regulation of stress-activated protein kinase signaling cascade| |regulation of JNK cascade| |regulation of microtubule cytoskeleton organization| |protein autophosphorylation| |cell cycle checkpoint| |regulation of G2/M transition of mitotic cell cycle| |regulation of cell cycle G2/M phase transition| |negative regulation of mitotic cell cycle phase transition| |regulation of microtubule-based process| |negative regulation of cell cycle phase transition| |regulation of stress-activated MAPK cascade| |regulation of stress-activated protein kinase signaling cascade| |protein kinase activity| |positive regulation of MAP kinase activity| |negative regulation of mitotic cell cycle| |negative regulation of cell cycle process| |activation of protein kinase activity| |positive regulation of protein serine/threonine kinase activity| |anatomical structure homeostasis| |regulation of MAP kinase activity| |regulation of actin cytoskeleton organization| |regulation of supramolecular fiber organization| |protein serine/threonine kinase activity| |MAPK cascade| |negative regulation of organelle organization| |regulation of actin filament-based process| |signal transduction by protein phosphorylation| |regulation of mitotic cell cycle phase transition| |regulation of cell cycle phase transition| |microtubule cytoskeleton organization| |DNA repair| |regulation of protein serine/threonine kinase activity| |positive regulation of protein kinase activity| |regulation of cytoskeleton organization| |positive regulation of MAPK cascade| |negative regulation of cell cycle| |positive regulation of kinase activity| |mitotic cell cycle process| |regulation of mitotic cell cycle| |positive regulation of transferase activity| |microtubule-based process| |mitotic cell cycle| |perinuclear region of cytoplasm| |negative regulation of cellular component organization| |regulation of cellular response to stress| |DNA metabolic process| |regulation of cell cycle process| |regulation of MAPK cascade| |cellular response to DNA damage stimulus| |regulation of protein kinase activity| |regulation of kinase activity| |cellular homeostasis| |apoptotic process| |protein phosphorylation| |regulation of transferase activity| |cell cycle process| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |programmed cell death| |positive regulation of phosphorylation| |cell death| |cytoskeleton organization| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |regulation of cell cycle| |positive regulation of protein modification process| |phosphorylation| |regulation of organelle organization| |cell cycle| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |regulation of response to stress| |ATP binding| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |homeostatic process| |positive regulation of signal transduction| |intracellular signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16773 * **Expression level (log2 read counts)**: 7.46 {{:chemogenomics:nalm6 dist.png?nolink |}}